Pricing Log in Create free account
Friday 6 November 2026 Export ALB’s income statement to Excel — free account

Albemarle Corporation

ALB Basic Materials Specialty Chemicals

Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.

Revenue
+18.8%
EPS
+225.6%
Free cash flow
+708.4%
Total debt
−48.1%

Quarter to September 2026, against a year earlier

98.44 3.47 +3.65%
Market cap
$11.6B
P/E
22.6×
Fwd P/E
9.9×
Dividend yield
1.65%
F-score
6/9
Altman Z
2.31
Beneish M
−3.71
Dividend safety
47/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Albemarle Corporation (ALB) SEC filings, changes and red flags

Red flags

  • Covenant breach

    Albemarle Corporation’s 10-K reports a breach of a debt covenant, or a waiver to avoid one

    The October 2024 amendment was entered into to modify the financial covenants under the 2022 Credit Agreement.

    10-K filed · The filing · sec.gov

  • Officer departure

    Albemarle Corporation reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Restatement

    Albemarle Corporation’s 10-K corrects an error in previously issued financial statements

    10-K filed · The filing · sec.gov

  • Impairment

    Albemarle Corporation reported a material impairment

    8-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 8 added · 4 removed · 51 modified
P2I1A: 2 modified
8-K Nov 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 26, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 5.03 Amendments to the articles or bylaws; change in fiscal year; 9.01 Financial statements and exhibits
8-K Sep 2, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Aug 19, 2026 5.02 Departure or appointment of directors or officers
10-Q Jun 30, 2026 P1I2: 18 added · 1 removed · 43 modified
P2I1A: 2 modified
8-K Aug 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 21, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 1, 2026 5.02 Departure or appointment of directors or officers
8-K May 5, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 17 added · 80 removed · 65 modified
P2I1A: 1 added
8-K May 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 13, 2026 5.02 Departure or appointment of directors or officers
8-K Mar 19, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 26, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 4 added · 3 removed · 24 modified
1A: 16 added · 23 removed · 75 modified
7: 30 added · 41 removed · 76 modified 		Covenant breach Restatement
8-K Feb 11, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 8, 2025 5.02 Departure or appointment of directors or officers
10-Q Sep 30, 2025 P1I2: 10 added · 7 removed · 47 modified
P2I1A: no changes
8-K Nov 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 23, 2025 1.01 Entry into a material definitive agreement; 2.06 Material impairment; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits Impairment
10-Q Jun 30, 2025 P1I2: 19 added · 1 removed · 42 modified
P2I1A: no changes
8-K Jul 30, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 30, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 12, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 31, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 14, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.